The use of extracorporeal pig liver perfusion for temporary liver support has been followed not infrequently by major bleeding with a fall in coagulation. factors and platelets, rather than a rise as hoped. In 18 experimental perfusions in which 1251-labelled fibrinogen was used as a marker there was in every instance a significant loss of the fibrinogen into the fluid supporting the liver in the perfusion chamber. Further, in 11 of the perfusions there was an additional loss into liver substance, this being associated with a very rapid fall in 1251 fibrinogen and platelets content of the perfusing fluid. Damage to the sinusoids from ischaemic damage incurred during removal of the liver could explain both the direct loss of fibrinogen and, as a result of intravascular coagulation, the associated loss within the perfused liver. No correlation could be found with biochemical function, but it proved possible to assess haematological safety before connexion of the patient to the perfusion by a shortened 125I fibrinogen test. This was done in three patients treated by five perfusions and in none was the thrombocytopenia or coagulation disturbance adversely affected.
Introduction
It is only 10 years since Eiseman et al. (1961) suggested using an isolated animal liver for the treatment of patients with hepatic failure. The liver most commonly used has been that of the pig (Eiseman, 1966; Norman et al., 1966; Watts et al., 1967; Abouna et al., 1969; Ranek et al., 1971) , although calf (Condon and Bombeck, 1970; Battersby et al., 1971) , monkey (Abouna et al., 1970 (Abouna et al., , 1972 , and cadaver human (Sen et al., 1966; Abouna et al., 1970) livers have been used. Such treatment has often resulted in the patient recovering from coma, even in a dramatic fashion, but the overall results from a number of centres have been poor. While this is partly a reflection of the severity of fulminant hepatic failure many deaths have been due to bleeding which has followed the perfusion. In some instances (Abouna et al., 1969 (Abouna et al., , 1970 correction of haemostatic deficiencies in the patient has been attributed to the synthesis of coagulation factors by the perfused liver, but in most patients with bleeding this has been made worse rather than better. Parbhoo et al. (1971) , in a report of six perfusions, concluded that it is a valuable form of therapy, though it is to be noted that two treatments were curtailed by haematomata in the patient; one patient died of widespread bleeding beginning after the first perfusion and increasing after the second, and one patient died of bleeding two hours after -a perfusion. The severe bleeding was associated with reduced platelet levels.
Nevertheless, at the moment this represents the most promising form of temporary liver support , and in this paper we report experimental studies on the mechanism of the coagulation disturbance, with its relation to biochemical function of the perfused liver. A test to determine haematological safety was developed and its value shown in five perfusions carried out in treatment of three patients in hepatic coma, none of these leading to significant worsening of the thrombocytopenia or coagulation disturbance.
Technique for Extracorporeal Perfusion
The liver was obtained under aseptic conditions from a pig previously anaesthetized through an endotracheal tube. To minimize ischaemic damage the liver was cooled to 7°C by perfusion of fluid through the portal vein. The cooling solution used, which also served to flush out the pig blood, was similar in ionic concentration and heparin content to that described by Abouna (1968) , except that dextran and trometamol were replaced by Rheomacrodex and a phosphate buffer respectively. The liver was then floated in a bath of saline within the perfusion chamber of a closed circuit ) which allowed delivery of heparinized, oxygenated, fresh human blood to the portal vein as a smooth gravity flow from a height of 15 cm and to the hepatic artery under a pulsatile pressure of 90 mm Hg systolic. Rewarming to 38°C was performed slowly over 30 minutes. In the experimental studies bile salts necessary for the secretion of bile were provided by infusion of sodium taurocholate into the circulating blood at a constant rate of 12 ,tEq/ min. Fluid exuding from the liver surface and cut hilar lymphatics ("ascites") passed direct into the surrounding saline, the volume of which was kept constant by the use of an overflow cannula from the chamber to the circuit. During clinical use this overflow was collected separately. The patient was connected to the circuit by means of two cannulae (Plexitron U51 1, Travenol) introduced into the vena cava through one or both long saphenous veins. These cannulae passed in opposite directions across a double-headed roller pump controlled at a speed independent of the flow in the liver circuit. Thus flows to and from the patient were about equal (250-400 ml/min contributing to a total liver flow of 800-900 ml/min), but any small inequality found by frequent monitoring of the patient's weight (facilitated by the use of a weighing bed), blood pressure, and central venous pressure, together with observation of levels of blood in the circuit reservoirs, was corrected by temporary clamping of the cannula leading to or from the patient.
Experimental Studies on Coagulation
In preliminary experiments we found that recirculation of fresh heparinized blood through the circuit without a liver in the perfusion chamber caused little if any lowering of platelet levels. This was not so, however, when the liver was in the circuit, and in 18 such studies there was a fall in the platelet count of 25-75% of the initial level after two hours of perfusion. The reduction in the platelet count was not correlated with the warm or cold ischaemia times or the duration of rewarming.
In these 18 studies we also attempted to determine quantitatively whether there was a loss of coagulation factors as well as of platelets. At the beginning of each study 10 ,uCi of 125I fibrinogen was introduced into the perfusing blood and its subsequent rate of disappearance determined by serial sampling. The counts recorded in each sample included those due to free iodine and fibrinogen breakdown products in addition to those of the labelled fibrinogen. To determine the latter, the sample was recounted after the addition of thrombin, calcium, and protamine and removal of the resulting "thrombus"; the difference between the two counts giving that due to the fibrinogen, including small amounts of large molecular weight fibrin/fibrinogen degradation products. Serial samples of saline from the perfusion chamber were also counted, and since the volumes of the perfusate and saline were known the absolute amount of 125I fibrinogen in perfusate or in saline and ascites could be determined at any time. The results showed that the loss of 125I fibrinogen from the perfusate was similar to the rate of decrease in circulating platelets over the four hours of perfusion ( Fig. 1) . Labelled fibrinogen was detected in the ascites in all 18 studies, and in seven of these this accounted for almost all the fibrinogen lost from the perfusate. In the other 11 studies the amount lost into ascites was similar but the total loss from perfusate was greater (Table I) . This additional loss appeared to be in the liver for fibrin deposits were shown on microscopical examination within the sinusoids (Fig. 2) , whereas they were less promient in the seven perfusions in which the total loss of fibrinogen was less and accountable for by that appearing in the ascites. In those perfusions where fibrinogen was lost into liver as well as into ascites the measured rate of 151I fibrinogen disappearance from the perfusate during the first hour was more rapid (ti < 120 mm) than in the other seven perfusions (ti > 120 min). In none of these five perfusions did the patient's platelet count fall significantly (Table II) and haemorrhage was a problem only in Case 1, a patient who was bleeding profusely from the gastrointestinal tract before perfusion. In only one instance was the prothrombin time improved although the serum bilirubin was lowered in each perfusion, and the depth of coma was reduced in Case 3. The lack of improvement in conscious level in Case 2 may perhaps be explained by damage to the brain from the earlier episode of profound hypoglycaemia.
Discussion
The loss of fibrinogen to the fluid surrounding the pig liver during perfusion has not been reported previously and could represent a significant hazard for the patient, particularly if other coagulation factors are lost to the same extent. The radioactive fibrinogen studies also showed an additional site of loss in nearly two-thirds of the perfusions-namely, in the pig's liver. The most likely cause for the latter is intravascular coagulation developing as a consequence of ischaemic damage to the liver. The fibrin seen in the sinusoids of the liver at the end of perfusion is evidence of its occurrence. Such a process would also explain the parallel loss of platelets seen, by incorporation into the fibrin thrombi and adherence to damaged sinusoidal endothelium. Hutchinson et al. (1968) reported both in dogs and man a significant fall in blood platelets immediately on revascularization of the liver after transplantation and showed that it was not necessary to invoke an imm-ine process, for the same occurred in dogs when the liver was made temporarily ischaemic in situ. On electron microscopy passage of platelets across a damaged sinusoidal endothelium was also seen.
The direct diffusion of the administered fibrinogen from perfusing fluid to surface is probably also a secondary effect of ischaemic damage to the sinusoidal wall incurred during preparation of the liver for perfusion. There was no correlation in our series between the extent of the fibrinogen loss, either into ascites or within the liver, and the warm or cold ischaemia times but there is other evidence pointing to hepatocyte damage. For instance, Strebel et al. (1969) showed that the isolated perfused liver has a lower maximal excretory rate for bromsulphthalein than the normal animal and in the present studies we found considerably less bromsulphthalein excreted into bile than was removed from the perfusate.
The occurrence of intravascular coagulation in the perfused liver may make perfusion more difficult, but the main adverse consequence is consumption of the circulating coagulation factors. Radioactive fibrinogen and other coagulation studies in patients with fulminant hepatic failure indicate that the haemorrhagic diathesis is, in addition to impairment of hepatic synthesis, due to the development of disseminated intravascular coagulation, presumably initiated by necrosis of liver cells and release of tissue thromboplastins (Rake et al., 1970 (Rake et al., , 1971 (Cox, Bond, Podmore, and Rose, 1964) and impaired ascorbic acid nutrition could be the result of diminished absorption of the vitamin due to the therapeutic hypochlorhydria. The present study was constructed to confirm the effect of vagotomy on ascorbic acid nutrition in a larger group of patients, and to determine whether a relation exists between gastric acid output and the leucocyte ascorbic acid level after vagotomy.
Methods
Of the 40 patients originally studied, seven defaulted from follow-up and have been excluded. The remainder (27 men and 6 women) were aged 18 to 68 years, mean 45 years (S.D. i 11 3). All had long-standing symptoms and had been selected for surgery before inclusion in this survey.
The dietary ascorbic acid levels were estimated before and after surgery by means of a questionnaire based on the tables of McCance and Widdowson (1960) . Results were expressed as mg/day. Leucocyte ascorbic acid levels were estimated by the method of Denson and Bowers (1961) . Fractionation of the cells and plasma was carried out within a few minutes of collection to min iize the uptake of. ascorbic acid by the cells from the plasma. Though this method in fact measures the ascorbic acid content of the buffy layer, which contains both leucocytes and platelets, the results are conventionally expressed as ,ig/10 W.B.C. When the white count or platelet count is abnormal a correction factor is necessary (Gibson, Moore, and 
